A Case of Posterior Reversible Encephalopathy Syndrome Associated With Pembrolizumab and Cetuximab Combination Therapy

By sjmartinez • November 20, 2024

Patel N, Karanth R, Isaacs DJ, Cohen J, Wong DJ, Delshad SD. A Case of Posterior Reversible Encephalopathy Syndrome Associated With Pembrolizumab and Cetuximab Combination Therapy. Cureus. 2024 Oct 19;16(10):e71867. doi: 10.7759/cureus.71867. PMID: 39559603; PMCID: PMC11573227.

Tags: cancer immunotherapy, Cetuximab, General Internal Medicine, hematology-oncology, Hematology/Oncology, Hospitalist, immune-related adverse event, irae, pembrolizumab side effect, posterior reversible encephalopathy syndrome, pres, Publications

The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection on Long-Term Symptoms in the Innovative Support for Patients With SARS-CoV-2 Infections Registry (INSPIRE)

Openshaw JJ, Chen J, Rodriguez R, Gottlieb M, McCullough K, Santangelo M, Hill MJ, Gatling K, Idris AH, McDonald S, Wisk LE, Dyal J, Wang[...]

Clinical and Molecular Characteristics of X-linked Agammaglobulinemia Patients 55 Years or Older

Chin AT, Ochs HD, Kobayashi R, Abolhassani H, Alachkar H, Barmettler S, Baxendale H, Boiling K, Cantanzaro J, Chua I, Coulter T, Cunningham-Rundles C, Elcombe[...]

Impact of lifting school mask mandates on community SARS-CoV-2 cases, hospitalizations, and deaths: a retrospective observational study

Ertem Z, Danesharasteh A, Anand ST, Jackson NJ, Nelson RE, Schechter-Perkins EM, Fisher L, Doron S, Branch-Elliman W. Impact of lifting school mask mandates on[...]